Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lih-Ling Lin

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|October 16, 2004
NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approachJun Kuai, Joe Wooters, J Perry Hall, et al.
The Journal of Biological Chemistry|August 18, 2018
Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signalingSaurav De, Fawziya Karim, Ezechielle Kiessu, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2011
Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitorsYike Ni, Ariamala Gopalsamy, Derek Cole, et al.
The Journal of Biological Chemistry|February 26, 2014
Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific mannerLeah Cushing, Wayne Stochaj, Marshall Siegel, et al.
Genome Medicine|January 24, 2012
The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controlsMarcus Ronninger, Yongjing Guo, Klementy Shchetynsky, et al.
Journal of Pharmacological and Toxicological Methods|March 30, 2007
A rat pharmacokinetic/pharmacodynamic model for assessment of lipopolysaccharide-induced tumor necrosis factor-alpha productionQin Wang, Yuhua Zhang, J Perry Hall, et al.
Journal of Autoimmunity|July 14, 2017
The epigenetic architecture at gene promoters determines cell type-specific LPS toleranceKerstin Klein, Mojca Frank-Bertoncelj, Emmanuel Karouzakis, et al.
Annals of the Rheumatic Diseases|December 4, 2014
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblastsKerstin Klein, Pawel A Kabala, Aleksander M Grabiec, et al.
Scientific Reports|June 3, 2020
Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease courseAttila A Seyhan, Bernard Gregory, Adam P Cribbs, et al.
Cell Research|January 5, 2023
Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activationGang Du, Linlin Zhao, Yumei Zheng, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|October 16, 2004
NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approachJun Kuai, Joe Wooters, J Perry Hall, et al.
The Journal of Biological Chemistry|August 18, 2018
Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signalingSaurav De, Fawziya Karim, Ezechielle Kiessu, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2011
Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitorsYike Ni, Ariamala Gopalsamy, Derek Cole, et al.
The Journal of Biological Chemistry|February 26, 2014
Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific mannerLeah Cushing, Wayne Stochaj, Marshall Siegel, et al.
Genome Medicine|January 24, 2012
The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controlsMarcus Ronninger, Yongjing Guo, Klementy Shchetynsky, et al.
Journal of Pharmacological and Toxicological Methods|March 30, 2007
A rat pharmacokinetic/pharmacodynamic model for assessment of lipopolysaccharide-induced tumor necrosis factor-alpha productionQin Wang, Yuhua Zhang, J Perry Hall, et al.
Journal of Autoimmunity|July 14, 2017
The epigenetic architecture at gene promoters determines cell type-specific LPS toleranceKerstin Klein, Mojca Frank-Bertoncelj, Emmanuel Karouzakis, et al.
Annals of the Rheumatic Diseases|December 4, 2014
The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblastsKerstin Klein, Pawel A Kabala, Aleksander M Grabiec, et al.
Scientific Reports|June 3, 2020
Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease courseAttila A Seyhan, Bernard Gregory, Adam P Cribbs, et al.
Cell Research|January 5, 2023
Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activationGang Du, Linlin Zhao, Yumei Zheng, et al.
Pageof 6